
Odaberite svoju etiketu
prikazano izravno na bočiciChonluten
Bioregulators
- Šalje se iz Njemačke
Narudžba
- DHL s praćenjem
- Diskretno pakiranje
Na prvi pogled
Chonluten u brojkama
Ključni podaci iz našeg leksikona.
Cijeli članak u leksikonu- Class
- Short bioregulator peptideKhavinson cytogen
- Use
- Subcutaneousin mg
- Sizes
- 20 mg1 size in the shop
What studies show
The source in the lexiconPeptides and aging: review of tissue-specific bioregulators (Khavinson program) (opens in a new tab)
Khavinson, Neuro Endocrinology Letters, 2002
Za Chonluten još nema laboratorijske analize. Glasaj za toDajte sami na testiranje, mi plaćamo polaSve laboratorijske analize
Znanje
Sve o Chonluten
Detaljne informacije uskoro.
Doziranje
Učitavanje podataka o doziranju …
Dobro je imati
Što vam uz to treba
Bakteriostatska voda automatski se dodaje u košaricu. Štrcaljke i maramice jednim klikom.
Inzulinske štrcaljke
10 kom. · 5.50 €
Alkoholne maramice
50 kom. · 10 €
Koliko vode?
Jedinice na štrcaljki za veličinu vaše bočice.
Otvori kalkulator →Is Chonluten approved or studied in humans?
As of 26 October 2026 the registry ClinicalTrials.gov lists no trial with Chonluten. A review by the Khavinson group writes that EDG was given on top of usual care in chronic bronchitis and strengthened its effect. It gives no figures. This has not been checked independently.
What is Chonluten made of?
Of three amino acids: glutamic acid, aspartic acid and glycine, EDG for short, molecular formula C11H17N3O8. In older papers the same tripeptide is called T-34.
What did the study in immune cells show?
A group from Italy, together with the Khavinson group, tested five Khavinson peptides on a human monocyte cell line. After stimulation with bacterial components Chonluten dampened the release of TNF. All five peptides lowered TNF and IL-6 in mature macrophages and reduced their sticking to stimulated vessel wall. It was a cell culture without animals and without humans.
What is known about the stomach?
Under the code T-34 the tripeptide normalised the production of protective and inflammatory proteins in a model of stomach ulcers by influencing the related genes. A review by the group therefore also lists it as protection for the stomach.
How does Chonluten differ from Bronchogen?
According to the Khavinson group both target the airways. Chonluten is a tripeptide (EDG), Bronchogen a tetrapeptide (AEDL). For Bronchogen there is a rat model of COPD, for Chonluten mainly data from immune cells and the stomach.
How is such a short peptide supposed to work?
The Khavinson group assumes that short peptides reach the cell nucleus and influence genes. On the computer EDG fits well into the transporters PepT1 and LAT1 of the cell membrane. The group also suspects an effect against tumours through this. Whether this happens in the body has not been shown.
Which side effects are known?
There are no solid data because Chonluten has never been tested in a registered human trial. Statements about good tolerability come from the research group itself.
Povezano
Srodni proizvodi
Bronchogen
Peptidi · Posebni proizvodi i podrška Posebni proizvodi i podrška
1 veličina
= 32 €/bočica
Cardiogen
Peptidi · Posebni proizvodi i podrška Posebni proizvodi i podrška
1 veličina
= 32 €/bočica
Cortagen
Peptidi · Posebni proizvodi i podrška Posebni proizvodi i podrška
1 veličina
= 32 €/bočica
Crystagen
Peptidi · Posebni proizvodi i podrška Posebni proizvodi i podrška
1 veličina
= 32 €/bočica
Chonluten